Answers are grounded in this paper and cite their sources.
The systemic immune-inflammation index (SII) is a composite biomarker reflecting thrombo-inflammatory status. Its diagnostic performance for preoperative deep vein thrombosis (DVT) remains unclear. This meta-analysis evaluated the diagnostic performance of SII for identifying preoperative DVT. PubMed, Embase, Web of Science, and Scopus were searched up to October 16, 2025, for observational studies examining SII and preoperative DVT. Two reviewers independently screened studies, extracted data, and assessed quality. Pooled diagnostic accuracy measures, including area under the receiver operating characteristic curve (AUC), sensitivity, and specificity, were calculated using random-effects models. Meta-regression, sensitivity analyses, and publication bias assessments were performed. Five retrospective cohort studies involving 4,097 patients were included. The pooled AUC of SII for predicting preoperative DVT was 0.671 (95% CI: 0.595–0.748). The pooled sensitivity was 0.591 (95% CI: 0.487–0.688), and pooled specificity was 0.780 (95% CI: 0.682–0.854). Formal tests did not suggest substantial publication bias, although their power was limited by the small number of studies. Exploratory meta-regression suggested that mean age may influence diagnostic performance, with higher accuracy observed in older populations. Sensitivity analyses confirmed the robustness of the results, and no substantial publication bias was detected. SII may be a potential adjunctive biomarker for preoperative DVT in selected orthopedic populations, but evidence is limited by retrospective designs, geographic restriction, clinical heterogeneity, and variable cutoffs. Prospective multicenter validation is warranted.
No takes yet. Share an insight, caveat, or question.
Ramezanipour et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: